(CercleFinance.com) – Median Technologies announces this evening that it has received agreement from the European Investment Bank for the drawing of the last tranche of the loan granted on December 18, 2019 and renegotiated at the end of 2022.
The funds of 8.5 million euros corresponding to the last tranche will be released at the beginning of January 2024.
This financing has a maturity of 5 years, and bears interest at 5% capitalized. Median also issued 300,000 BSAs to the EIB, at an exercise price of 4.465 euros, with an expiry date in 2035.
According to Fredrik Brag, Managing Director and founder of Median, this financing will allow the company to continue its investment plan and its early cancer diagnosis programs.
‘Combined with previous financing gathered in 2023, this operation strengthens our financial visibility and positions our cash flow horizon for the first half of 2025,’ he indicated.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
